Healthcare utilisation by patients with chronic cough

25/01/2019
29/05/2022
EU PAS number:
EUPAS27673
Study
Finalised
Study type

Study topic

Disease /health condition

Study type

Non-interventional study

Scope of the study

Other

If ‘other’, further details on the scope of the study

Healthcare resource utilisation

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Cross-sectional
Study drug and medical condition

Medical condition to be studied

Cough
Population studied

Short description of the study population

Consecutive patients with chronic cough (>8 weeks in duration) from a tertiary care specialist cough clinic (King’s College Hospital, London, UK) were evaluated between 2016 and 2018. The investigation, diagnosis, and management of chronic cough was assessed by clinicians according to the British Thoracic Society guidelines for the management of chronic cough in adults10. Inclusion criteria were a diagnosis of chronic cough, first attendance to a specialist cough clinic, and able to read and understand English. Exclusion criterion was respiratory tract infections within the preceding 4 weeks.

Age groups

  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Special population of interest

Other

Special population of interest, other

Chronic cough patients

Estimated number of subjects

100
Study design details

Main study objective

Mean and range of total healthcare cost per patient related to assessment for chronic refractory cough both before and after attendance to the specialist clinic and the diagnosis of chronic refractory cough.

Outcomes

Exploratory study of healthcare utilisation per patient with chronic cough, Association between healthcare utilisation and cough outcome measures.

Data analysis plan

Resource use will be combined with appropriate unit costs from national sources, where possible (such as NHS reference costs). Resource use considered to be related to cough will be included. Predictive modelling of total and annual costs according to cough severity VAS and quality of life measure.